Prevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Context: Necrotizing enterocolitis (NEC) is the most frequent gastrointestinal emergency in neonates. The microbiome of the preterm gut may regulate the integrity of the intestinal mucosa. Probiotics may positively contribute to mucosal integrity, potentially reducing the risk of NEC in neonates. Objective: To perform an updated systematic review and meta-analysis on the efficacy and safety of probiotics for the prevention of NEC in premature infants. Data Sources: Structured searches were performed in: Medline, Embase, and the Cochrane Central Register of Controlled Trials (all via Ovid, from 2013 to January 2015). Clinical trial registries and electronically available conference materials were also searched. An updated search was conducted June 3, 2016. Study Selection: Randomized trials including infants less than 37 weeks gestational age or less than 2,500 g on probiotic vs. standard therapy. Data Extraction: Data extraction of the newly-identified trials with a double check of the previously-identified trials was performed using a standardized data collection tool. Results: Thirteen additional trials ( n = 5,033) were found. The incidence of severe NEC (RR 0.53 95% CI [0.42–0.66]) and all-cause mortality (RR 0.79 95% CI [0.68–0.93]) were reduced. No difference was shown in culture-proven sepsis RR 0.88 95% CI [0.77–1.00]. Limitations: Heterogeneity of organisms and dosing regimens studied prevent a species-specific treatment recommendation from being made. Conclusions: Preterm infants benefit from probiotics to prevent severe NEC and death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lin, H.-C., Su, B.-H., Chen, A.-C., Lin, T.-W., Tsai, C.-H., Yeh, T.-F., & Oh, W. (2005) · Pediatrics · doi:10.1542/peds.2004-1463 · Cited by 660 · cited 4×
“Nine trials included infants exclusively fed breastmilk (Lin et al., 2005;Manzoni et al., 2006; Rougé et al., 2009; Samanta et al., 2009; Sinha et al., 2015; Tewari, Dubey & Gupta, 2015; Roy et al., 2014; Van Niekerk et al., 2014b).”
BackgroundInfluentialOral Probiotics Prevent Necrotizing Enterocolitis in Very Low Birth Weight Neonates
Bin-Nun, A., Bromiker, R., Wilschanski, M., Kaplan, M., Rudensky, B., Caplan, M., & Hammerman, C. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.03.054 · Cited by 590
Lin, H.-C., Hsu, C.-H., Chen, H.-L., Chung, M.-Y., Hsu, J.-F., Lien, R.-I., Tsao, L.-Y., Chen, C.-H., & Su, B.-H. (2008) · Pediatrics · doi:10.1542/peds.2007-3007 · Cited by 506 · cited 2×
“Eight trials reported outcome data on this weight group (Al-Hosni et al., 2012; Lin et al., 2008; Manzoni et al., 2006; Manzoni et al., 2009; Jacobs et al., 2013; Oncel et al., 2014; Costeloe et al., 2016; Roy et al., 2014).”
BackgroundBifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial
Costeloe, K., Hardy, P., Juszczak, E., Wilks, M., & Millar, M. R. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01027-2 · Cited by 387 · cited 8×
“Eight trials reported outcome data on this weight group (Al-Hosni et al., 2012; Lin et al., 2008; Manzoni et al., 2006; Manzoni et al., 2009; Jacobs et al., 2013; Oncel et al., 2014; Costeloe et al., 2016; Roy et al., 2014).”
BackgroundInfluentialGuidelines for feeding very low birth weight infants
Dutta, S., Singh, B., Chessell, L., Wilson, J., Janes, M., McDonald, K., Shahid, S., Gardner, V., Hjartarson, A., Purcha, M., et al. (2015) · Nutrients · doi:10.3390/nu7010423 · Cited by 321
Regulatory Oversight and Safety of Probiotic Use
Venugopalan, V., Shriner, K. A., & Wong-Beringer, A. (2010) · Emerging Infectious Diseases · doi:10.3201/eid1611.100574 · Cited by 216
Cited by
Use of Probiotics in Preterm Infants
Poindexter, B., COMMITTEE ON FETUS AND NEWBORN, Cummings, J., Hand, I., Adams-Chapman, I., Aucott, S. W., Puopolo, K. M., Goldsmith, J. P., Kaufman, D., Martin, C., et al. (2021) · Pediatrics · doi:10.1542/peds.2021-051485 · Cited by 171
“In the past 5 years, there have been numerous published systematic reviews.(21,22) Despite great heterogeneity among studies, the cumulative pooled risk ratio (RR) for NEC (including more than 10 000 infants) is strongly in favor of treatment with probiotics for the prevention of NEC.”
BackgroundProbiotics for Preterm Infants: A Strain‐Specific Systematic Review and Network Meta‐analysis
van den Akker, C. H. P., van Goudoever, J. B., Szajewska, H., Embleton, N. D., Hojsak, I., Reid, D., Shamir, R., & ESPGHAN Working Group for Probiotics, P. &. C. O. N. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001897 · Cited by 167
“On the other hand, most RCTs from other settings such as for example China used different combinations of strains that were not tested in the RCTs included here (29).”
Esaiassen, E., Hjerde, E., Cavanagh, J. P., Pedersen, T., Andresen, J. H., Rettedal, S. I., Støen, R., Nakstad, B., Willassen, N. P., & Klingenberg, C. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00347 · Cited by 102
Costa, R. L., Moreira, J., Lorenzo, A., & Lamas, C. C. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2394-3 · Cited by 105
“[24], which evaluated the efficacy and safety of probiotics in more than 5000 infants less than 37 weeks of gestation or weighing less than 2500 g, observed a reduction in the incidence of severe NE and overall mortality compared to the placebo group.”
BackgroundDeshmukh, M., & Patole, S. (2021) · Advances in Nutrition · doi:10.1093/advances/nmaa164 · Cited by 78
Prentice, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01641 · Cited by 52
“Systematic review of studies providing probiotics to low-birth weight infants in neonatal units, suggest a reduction in grade II or III NEC and all-cause mortality, though no significant reductions in sepsis (289, 290).”
BackgroundTargeted Release of Probiotics from Enteric Microparticulated Formulations
Yus, C., Gracia, R., Larrea, A., Andreu, V., Irusta, S., Sebastian, V., Mendoza, G., & Arruebo, M. (2019) · Polymers · doi:10.3390/polym11101668 · Cited by 47
Metadata
- Authors
- Sawh, S. C., Deshpande, S., Jansen, S., Reynaert, C. J., & Jones, P. M.
- Venue
- PeerJ
- Publisher
- PeerJ
- Published
- 2016-10-05
- Volume
- 4
- Pages
- e2429
- ISSN
- 2167-8359 (ISSN-L)
- OpenAlex
- W2528175253
- Cited by
- 133
- References
- 6
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.